The measurement of prescription drug prices is a major source of bias in the MCPI.
Drug; when they are first introduced their prices are relatively high, and later in the cycle their prices decline.
The weight given to the generic drug is too small, its market share continue to grew.
The generic drug is treated as a separate good; the price decline experienced by those consumer.